FARE Blog

At last weekend’s annual scientific meeting of the American Academy of Allergy, Asthma & Immunology, Aimmune Therapeutics and DBV Technologies presented updates on the two immunotherapies for peanut allergy that have progressed farthest in the U.S. Food and Drug Administration’s approval process for bringing new drugs to market. Yesterday, we posted on the FARE Blog some of the data reported by Aimmune. Here, we present findings released by DBV.

At last weekend’s annual scientific meeting of the American Academy of Allergy, Asthma & Immunology, Aimmune Therapeutics and DBV Technologies presented updates on the two immunotherapy approaches for peanut allergy that have progressed farthest in the U.S. Food and Drug Administration’s approval process for bringing new drugs to market.

This weekend’s annual scientific meeting of the American Academy of Allergy, Asthma & Immunology features hundreds of research presentations, many of which provide noteworthy new findings in the field of food allergy. FARE staff are attending the San Francisco conference along with thousands of allergists, immunologists, researchers and other healthcare providers. Here are highlights from some of Saturday’s presentations focusing on the food allergy field.

Last month, researchers at Stanford University published a study that shed new light on blood cells that play an essential role in peanut allergy. These very rare IgE B cells make peanut-specific IgE antibodies that, when bound to peanut protein, can trigger the release of histamines and other molecules that cause reaction symptoms.

Two recently released large-scale studies of food allergy prevalence have resulted in an update of FARE’s frequently cited statistics that provide estimates on how many people are living with this potentially life-threatening disease.

No matter who you’re rooting for this Sunday, these protein-rich, top-eight free recipes are the perfect fuel for your allergy-friendly party. Have fun and stay safe as you cheer on your favorite team!

New research has found that bacteria in the feces of healthy human babies protect mice who are sensitized to cow’s milk against severe reactions to milk protein. In contrast, bacteria in the stools of human infants with cow’s milk allergy do not protect milk-sensitized mice from anaphylactic reaction to milk.

A survey of 40,000 U.S. adults finds that 11 percent – or more than 26 million individuals nationwide – have a food allergy, while an additional 8 percent believe they have a food allergy but report symptoms likely to result from food intolerance. Forty-five percent of the adults who report convincing food allergy symptoms are allergic to more than one food, and nearly half developed at least one food allergy during adulthood.

Community support fuels FARE initiatives to fund research, share information, advocate for better policies and raise food allergy awareness. In turn, FARE supports community efforts by creating tools that help volunteers spread knowledge and awareness effectively.

In a Nov. 21, 2018 webinar, Building the Village Food Allergy Families Need, health strategist and innovator Glenna Crooks, PhD, describes how the social networks of your child with food allergy can help your family manage this serious medical condition. Her approach to communicating vital health information to members of your child’s networks is supported with additional online resources that you can access through FARE.